Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients

Antonio Matteo Amadu¹, Luigi Angelo Vaira^{2

3}, Jerome R Lechien^{4

5}, Mariano Scaglione⁶, Luca Saba⁷, Maria Luisa Lampus⁷, Stefano Giorgio Profili¹, Serge-Daniel Le Bon⁸, Giovanni Salzano^{2

9}, Fabio Maglitto^{2

9}, Sven Saussez^{4

5}, Paolo Boscolo-Rizzo¹⁰, Claire Hopkins², Giacomo De Riu^{11

12}

Affiliations

¹ Diagnostic Imaging 1 Unit, University Hospital of Sassari, Sassari, Italy.
² Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
³ Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy.
⁴ COVID-19 Task Force of the Young Physicians Group of the International Federation of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
⁵ Department of Human and Experimental Oncology, Faculty of Medicine UMons Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
⁶ Diagnostic Imaging 2 Unit, University Hospital of Sassari, Sassari, Italy.
⁷ Department of Radiology, University Hospital of Cagliari, Cagliari, Italy.
⁸ Department of Otorhinolaryngology, Centre Hospitalier Universitaire (CHU) Saint-Pierre, Brussels, Belgium.
⁹ Department of Maxillofacial Surgery, University of Naples "Federico II", Naples, Italy.
¹⁰ Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.
¹¹ ENT Department, King's College, London, UK.
¹² British Rhinological Society (President), London, UK.

Antonio Matteo Amadu et al. Int Forum Allergy Rhinol. 2022 Jan.

. 2022 Jan;12(1):103-107.

doi: 10.1002/alr.22869. Epub 2021 Jul 22.

¹ Diagnostic Imaging 1 Unit, University Hospital of Sassari, Sassari, Italy.
² Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
³ Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy.
⁴ COVID-19 Task Force of the Young Physicians Group of the International Federation of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
⁵ Department of Human and Experimental Oncology, Faculty of Medicine UMons Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
⁶ Diagnostic Imaging 2 Unit, University Hospital of Sassari, Sassari, Italy.
⁷ Department of Radiology, University Hospital of Cagliari, Cagliari, Italy.
⁸ Department of Otorhinolaryngology, Centre Hospitalier Universitaire (CHU) Saint-Pierre, Brussels, Belgium.
⁹ Department of Maxillofacial Surgery, University of Naples "Federico II", Naples, Italy.
¹⁰ Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.
¹¹ ENT Department, King's College, London, UK.
¹² British Rhinological Society (President), London, UK.

No abstract available

Keywords: COVID-19; SARS-CoV-2; anosmia; chest CT; coronavirus; hyposmia; olfactory; pneumonia; recovery; smell.

Conflict of interest statement

The authors declare that they have no competing interests.

1. Aziz M, Goyal H, Haghbin H, Lee‐Smith WM, Gajendran M, Perisetti A. The association of “loss of smell” to COVID‐19: a systematic review and meta‐analysis. Am J Med Sci. 2021;361:216‐225. - PMC - PubMed
1. Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID‐19 patients: correlation with disease severity and short‐term prognosis. Eur Radiol. 2020;30:6808‐6817. - PMC - PubMed
1. Yang R, Li X, Liu H, et al. Chest CT severity score: an imaging tool for assessing severe COVID‐19. Radiol Cardiothorac Imaging. 2020;2:e200047. - PMC - PubMed
1. Vaira LA, Lechien JR, Khalife M, et al. Psychophysical evaluation of the olfactory function: European multi‐center study on 774 COVID‐19 patients. Pathogens. 2021;10:E62. - PMC - PubMed
1. Vaira LA, Hopkins C, Petrocelli M, et al. Efficacy of corticosteroid therapy in the treatment of long‐lasting olfactory disorders in COVID‐19 patients. Rhinology. 2021;59:21‐25. - PubMed